Phase 1 trial of everolimus and radiation therapy for salvage treatment of biochemical recurrence in prostate cancer patients following prostatectomy

V Narayan, N Vapiwala, R Mick, P Subramanian… - International Journal of …, 2017 - Elsevier
Purpose In up to half of patients treated with salvage radiation therapy (SRT) for rising
prostate-specific antigen levels, a second biochemical recurrence ultimately develops …
被引用次数：22 相关文章

Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy.

V Narayan, N Vapiwala, R Mick… - … Journal of Radiation …, 2016 - europepmc.org
Purpose In up to half of patients treated with salvage radiation therapy (SRT) for rising
prostate-specific antigen levels, a second biochemical recurrence ultimately develops …

Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

V Narayan, N Vapiwala, R Mick, P Subramanian… - International Journal of …, 2017 - infona.pl
In up to half of patients treated with salvage radiation therapy (SRT) for rising prostate-
specific antigen levels, a second biochemical recurrence ultimately develops. Phosphatase …

Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

V Narayan, N Vapiwala, R Mick… - … Journal of Radiation …, 2017 - pure.johnshopkins.edu
Purpose In up to half of patients treated with salvage radiation therapy (SRT) for rising
prostate-specific antigen levels, a second biochemical recurrence ultimately develops …

Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

V Narayan, N Vapiwala, R Mick… - International Journal of …, 2017 - inis.iaea.org
[en] Purpose: In up to half of patients treated with salvage radiation therapy (SRT) for rising
prostate-specific antigen levels, a second biochemical recurrence ultimately develops …

Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

V Narayan, N Vapiwala, R Mick, P Subramanian… - International Journal of …, 2017 - osti.gov
Purpose: In up to half of patients treated with salvage radiation therapy (SRT) for rising
prostate-specific antigen levels, a second biochemical recurrence ultimately develops …

Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

V Narayan, N Vapiwala, R Mick… - … journal of radiation …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose In up to half of patients treated with salvage radiation therapy (SRT) for rising
prostate-specific antigen levels, a second biochemical recurrence ultimately develops …

Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

V Narayan, N Vapiwala, R Mick… - International Journal of …, 2017 - redjournal.org
Purpose In up to half of patients treated with salvage radiation therapy (SRT) for rising
prostate-specific antigen levels, a second biochemical recurrence ultimately develops …